论文信息 - Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. - 字舞流文

Leukemia relapse in donor cells after allogeneic bone-marrow transplantation.

ABLATIVE chemotherapy with allogeneic bone-marrow transplantation has become an accepted means of therapy for acute leukemia.1 It is the only treatment capable of producing long-term unmaintained r...

S. Latt | P. Newburger | R. Chaganti | R. O'reilly | K. Gustashaw | J. Pesando | M. Powers

[1] E. Scott,et al. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. , 1980, The New England journal of medicine.

[2] S. Latt,et al. Energy transfer-enhanced chromosome banding. An overview☆ , 1980 .

[3] R. Gelber,et al. Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. , 1980, Blood.

[4] S. Sallan,et al. Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. , 1978, Blood.

[5] G. Beebe,et al. Studies of the Mortality of A-Bomb Survivors: 6. Mortality and Radiation Dose, 1950-1974 , 1971 .

[6] Janet,et al. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. , 1978, Blood.

[7] R. Hoover,et al. Acute leukemia after alkylating-agent therapy of ovarian cancer. , 1977, The New England journal of medicine.

[8] K. Goh,et al. In vivo leukemic transformation: Cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells , 1977, American journal of hematology.

[9] P. Neiman,et al. Leukaemic transformation of engrafted human marrow cells in vivo. , 1971, Lancet.